Skip Navigation

VAERS Bibliography - May 2004

  1. Unlicensed Flu Vaccine Reported in USA. S.Afr.Med.J. 94 (3): 158-159; March, 2004.
  2. Measles Outbreak in a Boarding School--Pennsylvania, 2003. MMWR Morb.Mortal.Wkly.Rep. 53 (14): 306-309; April 16, 2004.

  3. Progress Toward Measles Elimination--Region of the Americas, 2002-2003. MMWR Morb.Mortal.Wkly.Rep. 53 (14): 304-306; April 16, 2004.

  4. Aaby, P.; Jensen, H.; Rodrigues, A.; Garly, M. L.; Benn, C. S.; Lisse, I. M.; Simondon, F. Divergent Female-Male Mortality Ratios Associated With Different Routine Vaccinations Among Female-Male Twin Pairs. Int.J.Epidemiol. 33 (2): 367-373; April, 2004.

  5. Ahmad, K. Vaccination Halts Meningitis Outbreak in Burkina Faso. Lancet. 363 (9417): 1290; April 17, 2004.

  6. Aldrete, J. A. Smallpox Vaccination in the Early 19th Century Using Live Carriers: the Travels of Francisco Xavier De Balmis. South.Med.J. 97 (4): 375-378; April, 2004.

  7. Aylward, R. B.; Cochi, S. L. Framework for Evaluating the Risks of Paralytic Poliomyelitis After Global Interruption of Wild Poliovirus Transmission. Bull.World Health Organ. 82 (1): 40-46; January, 2004.

  8. Balkhy, H. H.; Memish, Z. A.; Bafaqeer, S.; Almuneef, M. A. Influenza a Common Viral Infection Among Hajj Pilgrims: Time for Routine Surveillance and Vaccination. J.Travel.Med. 11 (2): 82-86; March, 2004.

  9. Barouni, A. S.; Augusto, C.; Queiroz, M. V.; Lopes, M. T.; Zanini, M. S.; Salas, C. E. BCG Lymphadenopathy Detected in a BCG-Vaccinated Infant. Braz.J.Med.Biol.Res. 37 (5): 697-700; May, 2004.

  10. Blanco, Quiros A.; Gimenez, Sanchez F.; Asensi, Botet F.; Bernaola, Iturbe E.; De Juan, Martin F.; Garcia, Perez J.; Garces, Sanchez M.; Gomez Campdera, J. A.; Picazo, J. J.; Pineda, Solas, V  [Vaccination Schedule of the Spanish Association of Pediatrics. Recommendations 2004]. An.Pediatr.(Barc.). 60 (5): 468-472; May, 2004.

  11. Blasiole, D. A.; Metzgar, D.; Daum, L. T.; Ryan, M. A.; Wu, J.; Wills, C.; Le, C. T.; Freed, N. E.; Hansen, C. J.; Gray, G. C.; Russell, K. L. Molecular Analysis of Adenovirus Isolates From Vaccinated and Unvaccinated Young Adults. J.Clin.Microbiol. 42 (4): 1686-1693; April, 2004.

  12. Bredin, C. P. Tuberculosis in the Ireland of 2003: It Hasn't Gone Away. Ir.Med.J. 97 (1): 6-7; January, 2004.

  13. Breeze, E.; Mangtani, P.; Price, G. M.; Kovats, S.; Roberts, J.; Fletcher, A. E. Trends in Influenza Vaccination Uptake Among People Aged Over 74 Years, 1997-2000: Survey of 73 General Practices in Britain. BMC.Fam.Pract. 5 (1): 8; April, 2004.

  14. Brydak, L. B.; Machala, M.; LAguna, P.; Rokicka-Milewska, R. Antibody Response to Influenza Vaccination in Splenectomized Patients in Poland. J.Clin.Immunol. 24 (3): 225-236; May, 2004.

  15. Check, E. Side Effects Leave Smallpox Vaccine in Limbo. Nature. 428 (6985): 789; April 22, 2004.

  16. Chi, R. C.; Neuzil, K. M. The Association of Sociodemographic Factors and Patient Attitudes on Influenza Vaccination Rates in Older Persons. Am.J.Med.Sci. 327 (3): 113-117; March, 2004.

  17. Chodaczek, G. [Adjuvants As Factors Improving Efficiency of Vaccination]. Postepy Hig.Med.Dosw. 58:47-59; March 2, 2004.

  18. Chong, C. Y.; Lim, S. H.; Ng, W. Y.; Tee, N.; Lin, R. V. Varicella Screening and Vaccination for Healthcare Workers at KK Women's and Children's Hospital. Ann.Acad.Med.Singapore. 33 (2): 243-247; March, 2004.

  19. Dine, M. S.; Hutchins, S. S.; Thomas, A.; Williams, I.; Bellini, W. J.; Redd, S. C. Persistence of Vaccine-Induced Antibody to Measles 26-33 Years After Vaccination. J.Infect.Dis. 189 Suppl 1:123-30; May 1, 2004.

  20. Dixon-Woods, M.; Brown, H.; Arthur, A.; Matthews, R.; Jagger, C. Organising Services for Influenza Vaccination for Older People. J.Health Serv.Res.Policy. 9 (2): 85-90; April, 2004.

  21. Everett, W. W.; Zaoutis, T. L.; Halpern, S. D.; Strom, B. L.; Coffin, S. E. Preevent Vaccination Against Smallpox: a Survey of Pediatric Emergency Health Care Providers. Pediatr.Infect.Dis.J. 23 (4): 332-337; April, 2004.

  22. Fine, M. The Rhode Island Influenza Vaccine Experience 1995-2003: Influenza Vaccine Price, Reimbursement, Availability, and Rhode Island's Influenza Vaccination Rate. Med.Health R.I. 87 (3): 79-80; March, 2004.

  23. Fine, M. The Rhode Island Adult Vaccination Experience 1995-2003: Public Health, Marketplace Values, and Lessons Learned About the Integrity of Medicine As a Profession. Med.Health R.I. 87 (3): 75-76; March, 2004.

  24. Fontanesi, J.; Shefer, A. M.; Fishbein, D. B.; Bennett, N. M.; De Guire, M.; Kopald, D.; Holcomb, K.; Stryker, D. W.; Coleman, M. S.  Operational Conditions Affecting the Vaccination of Older Adults. Am.J.Prev.Med. 26 (4): 265-270; May, 2004.

  25. Ford, E. S.; Williams, S. G.; Mannino, D. M.; Redd, S. C. Influenza Vaccination Coverage Among Adults With Asthma: Findings From the 2000 Behavioral Risk Factor Surveillance System. Am.J.Med. 116 (8): 555-558; April 15, 2004.

  26. Frederiksen, M. S.; Brenoe, E.; Trier, J. Erythema Multiforme Minor Following Vaccination With Paediatric Vaccines. Scand.J.Infect.Dis. 36 (2): 154-155; 2004.

  27. Freed, G. L. Criteria for Choosing a Specific Vaccine. Arch.Pediatr.Adolesc.Med. 158 (4): 311; April, 2004.

  28. Fringuelli, E.; Lepri, E.; Camilloni, B.; Neri, M.; Carrio, E.; Russano, A.; Spinozzi, F.; Iorio, A. M. Flow Cytometric Measurement of Intracellular IFN-Gamma Induction in Aged Subjects Before and After Parenteral Influenza Vaccination. Dev.Biol.(Basel). 115:55-9; 2003.

  29. Fuessl, H. S. [How Do We Deal With Tick Bites--Vaccination--Antibiotica--Immunotherapy?]. MMW.Fortschr.Med. 145 (15): 35; April 10, 2003.

  30. Gillet, A. M. [Is It Necessary to Vaccinate Against Variola?]. Med.Trop.(Mars.). 63 (6): 643-648; 2003.

  31. Gowda, R.; Cartwright, K.; Bremner, J. A.; Green, S. T. Yellow Fever Vaccine: a Successful Vaccination of an Immunocompromised Patient. Eur.J.Haematol. 72 (4): 299-301; April, 2004.

  32. Grondin, M. A.; Gerbaud, L.; Taillandier, S.; Jalenques, I.; Glanddier, P. Y. [Measurement of the Prevention Policy in the Hospital]. Presse Med. 33 (6): 373-377; March 27, 2004.

  33. Gupta, V.; Bandyopadhyay, S.; Bapuraj, J. R.; Gupta, A. Bilateral Optic Neuritis Complicating Rabies Vaccination. Retina. 24 (1): 179-181; February, 2004.

  34. Gurfinkel, E. P.; de la Fuente, R. L. Two-Year Follow-Up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex.Heart Inst.J. 31 (1): 28-32; 2004.

  35. Hanania, N. A.; Sockrider, M.; Castro, M.; Holbrook, J. T.; Tonascia, J.; Wise, R.; Atmar, R. L. Immune Response to Influenza Vaccination in Children and Adults With Asthma: Effect of Corticosteroid Therapy. J.Allergy Clin.Immunol. 113 (4): 717-724; April, 2004.

  36. Hanna, J. N.; Morgan, A. K.; McCulloch, B. G. Uptake of Influenza Vaccine Among Aboriginal and Torres Strait Island Adults in North Queensland, 2003. Commun.Dis.Intell. 28 (1): 80-82; 2004.

  37. Hempstead, K.; Bresnitz, E.; Howell-White, S.; Crabtree, D.; Scotto, Rosato N. Use of a State Regulation for Adult Vaccination. Am.J.Prev.Med. 26 (4): 311-314; May, 2004.

  38. Heymann, D. L. Polio Eradication: Finishing the Job and Protecting the Investment. Bull.World Health Organ. 82 (1): 1; January, 2004.

  39. Hussain, R.; Shahid, F.; Zafar, S.; Dojki, M.; Dockrell, H. M. Immune Profiling of Leprosy and Tuberculosis Patients to 15-Mer Peptides of Mycobacterium Leprae and M. Tuberculosis GroES in a BCG Vaccinated Area: Implications for Development of Vaccine and Diagnostic Reagents. Immunology. 111 (4): 462-471; April, 2004.

  40. Hutchins, S. S.; Baughman, A. L.; Orr, M.; Haley, C.; Hadler, S. Vaccination Levels Associated With Lack of Measles Transmission Among Preschool-Aged Populations in the United States, 1989-1991. J.Infect.Dis. 189 Suppl 1:108-15; May 1, 2004.

  41. Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Melbye, M. Childhood Vaccination and Type 1 Diabetes. N.Engl.J.Med. 350 (14): 1398-1404; April 1, 2004.

  42. Inoue, T.; Hayashi, N.; Tsuda, K. [Improvement of Tuberculin Test Results With BCG Vaccination in Set-City Primary School Children From 2000 to 2002]. Nippon Koshu Eisei Zasshi. 51 (2): 103-108; February, 2004.

  43. Ipp, M.; Cohen, E.; Goldbach, M.; Macarthur, C. Effect of Choice of Measles-Mumps-Rubella Vaccine on Immediate Vaccination Pain in Infants. Arch.Pediatr.Adolesc.Med. 158 (4): 323-326; April, 2004.

  44. Jee, Y. M.; Cheon, D. S.; Kim, K. S.; Lee, S. H.; Yoon, J. D.; Lee, S. W.; Go, U.; Yang, B. K.; Ki, M. R.; Choi, B. Y.; Cho, H. W. A Seroprevalence Study of Poliovirus Antibody Among Primary Schoolchildren in Korea. Epidemiol.Infect. 132 (2): 351-355; April, 2004.

  45. Kelly, H.; Worth, L.; Karapanagiotidis, T.; Riddell, M. Interruption of Rubella Virus Transmission in Australia May Require Vaccination of Adult Males: Evidence From a Victorian Sero-Survey. Commun.Dis.Intell. 28 (1): 69-73; 2004.

  46. Krueger, M.; Fluegge, K.; Krause, M. F.; Berner, R. Fatal Haemophilus Influenzaetype b Sepsis in a 10-Month-Old Infant Despite Complete Vaccination and Adequate Hib Antibodies. Eur.J.Pediatr. April 15, 2004. [Epub ahead of print].

  47. Kulkarni, V.; Nadgir, D.; Tapiawala, S.; Malabari, A.; Kalgikar, A.; Kela, R.; Nadkar, M.; Kamath, S.; Shah, A. Biphasic Demyelination of the Nervous System Following Anti-Rabies Vaccination. Neurol.India. 52 (1): 106-108; March, 2004.

  48. Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B. Persistence of Antibodies at 5-6 Years of Age for Children Who Had Received a Primary Series Vaccination With a Pentavalent Whole-Cell Pertussis Vaccine and a First Booster With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second Booster With a Tetravalent Acellular Vaccine at 5-6 Years of Age. Vaccine. 22 (11-12): 1406-1414; March 29, 2004.

  49. Letonturier, D. [Influenza Can Hide Other Infections]. Soins.Gerontol. (46): 42-45; March, 2004.

  50. Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus Influenzae Type b (Hib) in 5-6-Year-Old Children After Primary Vaccination and First Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second Booster. Vaccine. 22 (11-12): 1415-1422; March 29, 2004.

  51. March, J. B. DNA Vaccination - Research Tool or a Practical Reality? Expert.Rev.Vaccines. 3 (2): 113-117; April, 2004.

  52. McLaughlin, M. A. Thoughts on Rabies Vaccination Enforcement. J.Am.Vet.Med.Assoc. 224 (6): 834-835; March 15, 2004.

  53. Micco, E.; Gurmankin, A. D.; Armstrong, K. Differential Willingness to Undergo Smallpox Vaccination Among African-American and White Individuals. J.Gen.Intern.Med. 19 (5 Pt 1): 451-455; May, 2004.

  54. Morgan, O. W.; Meltzer, M.; Muir, D.; Hogan, H.; Seng, C.; Hill, J.; Beckford, J. Specialist Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From an Outbreak of Measles. Commun.Dis.Public Health. 6 (4): 330-333; December, 2003.

  55. Mullooly, J. P.; Maher, J. E.; Drew, L.; Schuler, R.; Hu, W. Evaluation of the Impact of an HMO's Varicella Vaccination Program on Incidence of Varicella. Vaccine. 22 (11-12): 1480-1485; March 29, 2004.

  56. Nolan, P. The Rhode Island Meningitis Vaccine Experience--Mass Vaccination Campaigns, Politics and Health Policy. Med.Health R.I. 87 (3): 65-67; March, 2004.

  57. Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of Tetanus-Specific Cellular and Humoral Responses Following Tetanus Vaccination in Human Lymphatic Filariasis. Infect.Immun. 72 (5): 2598-2604; May, 2004.

  58. Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. [The Tetanus in Italy and in the Campania Region: Retrospective Analysis. The Importance of Vaccinations]. Ig Sanita Pubbl. 59 (6): 383-392; November, 2003.

  59. Parve, J. Remove Vaccination Barriers for Children 12 to 24 Months. Nurse Pract. 29 (4): 35-38; April, 2004.

  60. Pazdiora, P.; Januska, J. [Dynamics of Antibody Formation After Vaccination Against Tick-Borne Encephalitis]. Epidemiol.Mikrobiol.Imunol. 53 (1): 17-21; February, 2004.

  61. Redd, S. C.; King, G. E.; Heath, J. L.; Forghani, B.; Bellini, W. J.; Markowitz, L. E. Comparison of Vaccination With Measles-Mumps-Rubella Vaccine at 9, 12, and 15 Months of Age. J.Infect.Dis. 189 Suppl 1:116-22; May 1, 2004.

  62. Rosen, J. B.; Breman, J. G. Malaria Intermittent Preventive Treatment in Infants, Chemoprophylaxis, and Childhood Vaccinations. Lancet. 363 (9418): 1386-1388; April 24, 2004.

  63. Santibanez, T. A.; Zimmerman, R. K.; Nowalk, M. P.; Jewell, I. K.; Bardella, I. J. Physician Attitudes and Beliefs Associated With Patient Pneumococcal Polysaccharide Vaccination Status. Ann.Fam.Med. 2 (1): 41-48; January, 2004.

  64. Singleton, J. A.; Wortley, P.; Lu, P. J. Influenza Vaccination of Persons With Cardiovascular Disease in the United States. Tex.Heart Inst.J. 31 (1): 22-27; 2004.

  65. Spoulou, V.; Giannaki, M.; Vounatsou, M.; Bakoula, C.; Grafakos, S. Long-Term Immunity to Measles, Mumps and Rubella After MMR Vaccination Among Children With Bone Marrow Transplants. Bone Marrow Transplant. April 12, 2004. [Epub ahead of print].

  66. Staines, D. R. Is Osteoporosis Linked to Vaccinations and Gulf War Syndrome? Med.Hypotheses. 62 (5): 670-673; 2004.

  67. Uiterwyk, S. H. Pneumococcal Vaccine: to Vaccinate or to Revaccinate--That Is the Question. Med.Health R.I. 87 (3): 68-71; March, 2004.

  68. Valdmanis, V.; Walker, D.; Fox-Rushby, J. Are Vaccination Sites in Bangladesh Scale Efficient? Int.J.Technol.Assess.Health Care. 19 (4): 692-697; 2003.

  69. Wagenpfeil, S.; Neiss, A.; Banz, K.; Wutzler, P. Empirical Data on the Varicella Situation in Germany for Vaccination Decisions. Clin.Microbiol.Infect. 10 (5): 425-430; May, 2004.

  70. Wakefield, A. J.; Harvey, P.; Linnell, J. MMR--Responding to Retraction. Lancet. 363 (9417): 1327-1328; April 17, 2004.

  71. Zhou, F.; Reef, S.; Massoudi, M.; Papania, M. J.; Yusuf, H. R.; Bardenheier, B.; Zimmerman, L.; McCauley, M. M. An Economic Analysis of the Current Universal 2-Dose Measles-Mumps-Rubella Vaccination Program in the United States. J.Infect.Dis. 189 Suppl 1:131-45; May 1, 2004.

  72. Zielinski, A.; Rosinska, M.; Czarkowski, M.; Rudowska, J. The Effectiveness of Vaccination With Whole-Cell Pertussis Vaccine by Age Group in Poland 1996-2001. Scand.J.Infect.Dis. 36 (2): 114-118; 2004.